Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Dermatology Company Profex Announces $15.5 Million Series A

publication date: Aug 27, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Profex, Inc., a dermatology drug company headquartered in Shanghai, raised $15.5 million in a Series A financing. The round was led by Trident Capital, an international venture capital firm, and joined by Mustang Ventures, Trident’s partner in China venture investing. The new capital will be used to increase the company’s sales efforts and to extend its geographical reach inside China. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...